This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Sep. 11, 2013



















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.


 



Magnetic nanoparticles for drug delivery
By Dr. Afsaneh Motamed-Khorasani
Targeted drug delivery is a major problem for the treatment of many diseases. Magnetic nanoparticles, or MNPs, can be considered as promising drug-delivery candidates due to their special properties. They can be handled easily by an external magnetic field and can be delivered by passive and active strategies. Furthermore, visualization has become easy in MRI scans due to the use of MNP. However, there are some drawbacks to the use of MNPs.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




AREA & ASSOCIATION NEWS


HIPAA changes go into effect on Sept. 23 — Is your pharmacy ready?
Smart Retailing
An overview of some changes to HIPAA and resources to help you ensure your pharmacy's compliance.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Registration now open for the AzPA Anticoagulation Certificate Program
AzPA


Completely revised, the AzPA Anticoagulation Certificate Program will be presented Oct. 25.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


What is 'dabs?'
AzPA
Dabs, otherwise known as butane hash oil, is an extremely potent extract created by passing butane through high-grade marijuana. Following the evaporation of the butane, a thick oil or resin remains. The oil is most commonly vaporized using a special water pipe known as a rig, although it can be consumed orally as well. Hash oil use has recently increased and is quickly becoming a more popular method of use among adolescents.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Working with pharmacies across America
By Kathleen Sebelius, secretary of Health and Human Services
Pharmacies across America are stepping up to help you understand and get ready for the Health Insurance Marketplace. And Kathleen Sebelius, secretary of Health and Human Services, wants to say "thank you." Families throughout the country look to their pharmacy as a place they can go to for honest, straightforward advice they can trust.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Worldwide pharmacist tweet-a-thon
AzPA
AzPA is joining with other pharmacy organizations and pharmacists around the world in a global tweet-a-thon on Oct. 3.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




PHARMACY UPDATES


Flu shot may dramatically reduce heart attack risk
Pharmacy Times
For middle-aged adults, getting a flu shot may pay added dividends by offering protection against heart attacks as well as seasonal influenza, according to the results of an Australian study published in Heart. In order to investigate an association between influenza infection and increased risk of heart attack reported in previous studies, the researchers conducted a case-control study in a tertiary referral hospital and in orthopedic outpatient clinics in Sydney during the winters of 2008, 2009 and 2010.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


E-cigarette use skyrockets among middle and high school students
American Pharmacists Association
Use of electronic cigarettes more than doubled from 2011 to 2012 among U.S. middle and high school students, according to data published by CDC. Findings from the National Youth Tobacco Survey indicated that the percentage of high school students who reported ever using an e-cigarette jumped from 4.7 percent in 2011 to 10.0 percent in 2012.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


CDC: 9 million Americans use prescription sleep aids
Pharmacy Times
Nearly 9 million, or approximately 4 percent, of adults in the United States take prescription drugs to help them sleep, according to a report released in August by the Centers for Disease Control and Prevention. The media and pharmaceutical companies have reported that sleep aid use has significantly increased over the past two decades, and the CDC report finds that use of prescription sleep aids varies by age, sex, race, education level and sleep habits.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    CVS bans doctors 'over-prescribing' pain meds (Drug Topics)
Pharmacies take after banks, offering cash rewards for new customers (The Post and Courier)
Awareness of orphan therapies offers opportunities for pharmacists (American Society of Health-System Pharmacists)
CDC encourages flu vaccination as soon as possible (American Pharmacists Association)
Most medications, vaccines safe for nursing mothers, infants (Medscape)

Don't be left behind. Click here to see what else you missed.


IN THE NEWS


US emergency contraceptive use on the rise
Medscape
Emergency contraceptive use has more than doubled since 2002, according to a new report published online by the National Center for Health Statistics, a division of the Centers for Disease Control and Prevention. The findings, based on 12,279 interviews with women aged 15 to 44 years during the 2006 to 2010 National Survey of Family Growth, revealed a rise in emergency contraceptive use from 0.9 to 2.2 percent.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword EMERGENCY CONTRACEPTIVE.


Look for patterns to optimize insulin therapy
Pharmacy Practice News
As the practice of pharmacy expands, more health-system pharmacists are assuming responsibility for optimizing diabetes and cardiovascular care for patients with Type 2 diabetes, particularly those on insulin therapy, according to a diabetes clinical pharmacist speaking at the American Society of Health-System Pharmacists 2013 Summer Meeting.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Hospira warns of glass particulates in some nonrecalled products
American Society of Health-System Pharmacists
In a letter dated Aug. 30, Hospira said that some of the company's lyophilized products for injection have been found, after reconstitution, to contain glass particulates. The company urged U.S. customers with specific lots of vecuronium bromide, vancomycin hydrochloride or erythromycin lactobionate to visually inspect the vials after reconstitution and not use them if particulates are present.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New device IDs disease-causing germs
HealthDay News
A new spectrometer system designed to identify 193 yeast and bacteria that are capable of making people sick has been approved by the FDA. The Vitek MS can screen for yeasts such as Candida and Malassezia and bacteria from the Staphylococcaceae and pneumonia families, the agency said in a news release. People with AIDS and others with weakened immune systems are most prone to infections from these germs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Texas pharmacy tied to outbreak holds inspection
The Associated Press via The News Tribune
Two hospitals in Corpus Christi, Texas, have reported 17 bacterial infections. The compounding pharmacy that these infections were linked to, however, has no evidence of contamination.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Pharmacists feeling pain over AMA resolution
Pharmacy Practice News
A bluntly worded American Medical Association resolution that was intended to curb a barrage of retail pharmacy phone calls to physicians requesting additional information about pain medication prescriptions has triggered a backlash from pharmacists.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
CVS bans doctors 'over-prescribing' pain meds
Drug Topics
In response to the federal crackdown on prescription fraud, CVS Caremark has told physicians it believes over prescribe controlled substances to take their business elsewhere.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


McNeil recalls Motrin infants' drops
American Society of Health-System Pharmacists
McNeil Consumer Healthcare recently announced the recall of about 200,000 bottles of ibuprofen infant drops because they may contain tiny plastic particles.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Texas pharmacy tied to outbreak holds inspection
The Associated Press via The News Tribune
Two hospitals in Corpus Christi, Texas, have reported 17 bacterial infections. The compounding pharmacy that these infections were linked to, however, has no evidence of contamination.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


How should medications be dosed in obese children?
Medscape
Childhood obesity has been increasing dramatically over the past several years, with its prevalence doubling or tripling between the 1970s and 1990s in numerous countries worldwide. In 2010, the World Health Organization estimated that over 42 million children younger than 5 years are overweight and about 75 percent of these are from developing countries. This population may be at risk for therapeutic failure or adverse drug effects.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New IBD drug, vedolizumab, receives priority review status for ulcerative colitis
Pharmacy Practice News
Takeda Pharmaceutical Company Ltd. announced that it received priority review status from the FDA for its drug vedolizumab, an investigational antibody for the treatment of adults with moderately to severely active Crohn's disease and ulcerative colitis. Takeda submitted a biologics license application to the FDA for the treatment of CD and UC; the UC application will receive priority review, and the application for CD will be reviewed under the standard timeline.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Sept. 11, 2013
Sept. 4, 2013
Aug, 28, 2013
Aug. 21, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063